Ampiroxicam
CAS No. 99464-64-9
Ampiroxicam( CP-65703 )
Catalog No. M16911 CAS No. 99464-64-9
The prodrug of piroxicam that is a nonsteroidal anti-inflammatory drug (NSAID).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 10MG | 34 | In Stock |
|
| 25MG | 70 | In Stock |
|
| 50MG | 105 | In Stock |
|
| 100MG | 157 | In Stock |
|
| 200MG | 235 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAmpiroxicam
-
NoteResearch use only, not for human use.
-
Brief DescriptionThe prodrug of piroxicam that is a nonsteroidal anti-inflammatory drug (NSAID).
-
DescriptionThe prodrug of piroxicam that is a nonsteroidal anti-inflammatory drug (NSAID).Rheumatoid Arthritis Approved.
-
In Vitro——
-
In Vivo——
-
SynonymsCP-65703
-
PathwayChromatin/Epigenetic
-
TargetCOX
-
RecptorCOX
-
Research AreaInflammation/Immunology
-
IndicationRheumatoid Arthritis
Chemical Information
-
CAS Number99464-64-9
-
Formula Weight447.4616
-
Molecular FormulaC20H21N3O7S
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCCOC(=O)OC(C)OC1=C(N(S(=O)(=O)c2c1cccc2)C)C(=O)Nc3ccccn3
-
Chemical NameCarbonic acid, ethyl 1-[[2-methyl-1,1-dioxido-3-[(2-pyridinylamino)carbonyl]-2H-1,2-benzothiazin-4-yl]oxy]ethyl ester
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
4-Biphenylacetic aci...
Felbinac (INN, or biphenylylacetic acid) is a topical medicine, belonging to the family of medicines known as non-steroidal anti-inflammatory drugs (NSAIDs) of the arylpropionic acid class.
-
Hirsutanonol
Hirsutanonol is a secondary metabolite from the bark of Alnus glutinosa. Hirsutanonol has potent antioxidant and free radical scavenging activities and exhibits an inhibition effect on mitochondrial lipid peroxidation. Hirsutanonol can be used for studies
-
Gaultherin
Gaultherin has analgesic, and anti-inflammatory activities.Gaultherin lacks gastric ulcerogenic effect, because of it released salicylate in intestine slowly, not in stomach and it left the cyclooxygenase-1 unaffected, which was the source of cytoprotective prostaglandins in gastric epithelium.
Cart
sales@molnova.com